IMPACT BIOMEDICAL INC (IBO) Stock Income Statement
NYSEARCA:IBO - NYSE Arca - US45259L2051 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 50.00K | 0.00 | |||
| Minority Interest Expense | 62.00K | 71.00K | 204.00K | 544.90K | |||
| Operating Expenses | 3.40M | 4.03M | 3.45M | 3.19M | |||
| Research and Development | 278.00K | 1.15M | 1.23M | 1.08M | |||
| Selling, General, and Administrative Expenses | 2.00M | 1.76M | 1.11M | 992.40K | |||
| Operating Income | -3.40M | -4.03M | -3.40M | -3.19M | |||
| Interest Income/Expense | 4.02M | -431.00K | -438.00K | -135.20K | |||
| Other Income/Expense | N/A | 52.00K | 66.00K | 77.40K | |||
| Non Recurring Items | -25.36M | 0.00 | -4.10M | N/A | |||
| Income Before Taxes | -24.74M | -4.41M | -7.88M | -3.24M | |||
| Income Tax | 33.00K | 0.00 | -621.00K | -1.40M | |||
| Net Income | -24.71M | -4.34M | -7.05M | -1.30M | |||
| EBITDA | -2.28M | -2.91M | -2.29M | -2.07M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -2.30 | -0.38 | -0.61 | -0.11 | |||
| Statistics | |||||||
| Profit Margin | N/A | N/A | -14102.00% | N/A | |||
| Operating Profit Margin | N/A | N/A | -6808.00% | N/A | |||
All data in USD